- Home
- MRKR vs OCG Comparison
MRKR vs OCG Comparison
Compare MRKR & OCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- OCG
- Stock Information
- Founded
- MRKR N/A
- OCG 2018
- Country
- MRKR United States
- OCG Hong Kong
- Employees
- MRKR N/A
- OCG N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- OCG Other Consumer Services
- Sector
- MRKR Health Care
- OCG Consumer Discretionary
- Exchange
- MRKR Nasdaq
- OCG Nasdaq
- Market Cap
- MRKR 21.9M
- OCG 25.1M
- IPO Year
- MRKR N/A
- OCG 2020
- Fundamental
- Price
- MRKR $2.16
- OCG $1.22
- Analyst Decision
- MRKR Strong Buy
- OCG
- Analyst Count
- MRKR 1
- OCG 0
- Target Price
- MRKR $19.00
- OCG N/A
- AVG Volume (30 Days)
- MRKR 53.9K
- OCG 9.8K
- Earning Date
- MRKR 11-14-2024
- OCG 11-12-2024
- Dividend Yield
- MRKR N/A
- OCG N/A
- EPS Growth
- MRKR N/A
- OCG N/A
- EPS
- MRKR N/A
- OCG N/A
- Revenue
- MRKR $5,395,849.00
- OCG $1,227,855.00
- Revenue This Year
- MRKR $64.48
- OCG N/A
- Revenue Next Year
- MRKR N/A
- OCG N/A
- P/E Ratio
- MRKR N/A
- OCG N/A
- Revenue Growth
- MRKR 79.04
- OCG N/A
- 52 Week Low
- MRKR $1.83
- OCG $0.91
- 52 Week High
- MRKR $5.99
- OCG $2.60
- Technical
- Relative Strength Index (RSI)
- MRKR 32.84
- OCG 47.73
- Support Level
- MRKR $1.83
- OCG $1.09
- Resistance Level
- MRKR $2.79
- OCG $1.24
- Average True Range (ATR)
- MRKR 0.28
- OCG 0.09
- MACD
- MRKR -0.09
- OCG -0.00
- Stochastic Oscillator
- MRKR 21.02
- OCG 41.94
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.
About OCG Oriental Culture Holding LTD
Oriental Culture Holding Ltd is an online provider of collectibles and artwork e-commerce services. The company also offers online and offline integrated marketing, storage, and technical maintenance service to customers in China and Hong Kong. It operates through one segment namely, e-commerce of artwork trading. It generates revenue through listing service fees, transaction fees, and other revenues collected from traders.